A MULTICENTER, OPEN-LABEL EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY AND TOLERABILITY OF FARICIMAB IN PATIENTS WITH DIABETIC MACULAR EDEMA
Research Grant
Administered By
Ophthalmology
Awarded By
Genentech, Inc.
Start Date
June 23, 2020
End Date
March 1, 2024
Administered By
Ophthalmology
Awarded By
Genentech, Inc.
Start Date
June 23, 2020
End Date
March 1, 2024